Archives

Serious complications are rare, with confusion and cognitive side effects most common

Findings seen in trial where calories were held constant for both groups

41.5 percent of difficult-to-treat resistance episodes were treated exclusively with traditional agents

Strong recommendation given for addition of SGLT-2 or GLP-1 agonist to metformin and lifestyle modifications

More than half of women with menstrual migraine report moderate-to-severe disability with their headaches

Medical system factors for delays in care seen less often than patient factors

Risk increased for attention-deficit/hyperactivity disorder, autism spectrum disorder, and intellectual disability

Combining self-sampling with phone-based patient navigation further increases screening participation

However, topical administration resulted in an 8.3 percent absolute increase in transfusion

Greatest effect seen during both the 12-month intervention and at six-month follow-up among patients at high risk for cardiovascular events